The use of heat therapy to treat diseases was very common in Africa. To date, the number of people using this form of therapy is very much on the decrease. Data on the molecular action mechanisms of how it might induce beneficial effects remain unknown. The aim of the present study was to make a contribution towards understanding the putative implication of Heat Shock Protein 70 (HSP70) in the pathophysiology of Type 2 Diabetes Mellitus (T2DM) and the hypothetical benefits of heat therapy through the establishment of a network of protein-protein interactions between Krüppel Like Factor 14 (KLF14), Transcription Factor 7 Like 2 (TCF7L2), Peroxisome Proliferator-Activated Receptor Gamma (PPARG) and HSP70 (HSPA4). Data were generated by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) software version 10.0. This was used to identify the known and predicted protein-protein interactions (including direct or physical and indirect or functional associations) in the KLF14, TCF7L2, PPARG and HSP70 protein networks. With the active prediction methods (Gene Fusion, Neighborhood, Co-occurrence, Co-expression, Experiments, Databases and Text Mining) as interaction sources, Medium Confidence (0.400) and maximum number of interactions were used to show no more than 50 at the first shell and none at the second shell parameters. Fifty (50) proteins were identified to interact with these four proteins, namely KLF14, TCF7L2, PPARG and HSP70, resulting in a network diagram with 54 nodes (gene/proteins) and 485 edges, representing protein-protein associations. The network showed that HSP70 strongly interacts with other heat shock proteins like HSP90. The HSPBP, a cytoplasmic co-chaperone 1, inhibits HSPA1A chaperone activity by changing the conformation of its ATP-binding domain, thus interfering with this function. Based on the data generated by this in silico study, the potential beneficial effects of heat therapy on T2DM could probably be coordinated by the HSP70 protein-protein interactions involved in cell life and in the susceptibility to T2DM.
Published in | Biochemistry and Molecular Biology (Volume 6, Issue 2) |
DOI | 10.11648/j.bmb.20210602.11 |
Page(s) | 19-24 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Heat Therapy, Type 2 Diabetes Mellitus, Protein-Protein Interactions
[1] | Guillausseau PJ, Meas T, Virally M, Laloi-Michelin M, Médeau V, Kevorkian JP. (2008). Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab, 34 Suppl 2: S43–S48. |
[2] | International Diabetes Federation: IDF Diabetes Atlas. 9th edition. 2019 Available at: http://www.idf.org/diabetesatlas. Accessed: January 05, 2021. |
[3] | Cauchi S. (2006). Transcription factor TCF7L2 genetic study in the French population: Expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes. 55: 2903–2908. |
[4] | Cauchi S. (2007). TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J. Mol. Med. 85: 777–782 |
[5] | Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445: 881–885. |
[6] | McCarthy MI. (2010). Genomics, Type 2 Diabetes, and Obesity. New England Journal of Medicine. 363: 2339–2350 |
[7] | Loss RJ, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB. (2007). TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes. 56: 1943–1947. |
[8] | Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J. (1998). A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 20 (3): 284–287. |
[9] | Kerrin SS, Asa KH, Grundberg E, Nica AC, Thorleifsson G, Kong A, Thorsteindottir U, So-Youn S, Hannah BR, the GIANT Consortium, the MAGIC Investigators, the DIAGRAM Consortium, Soranzo N, Ahmadi KR, Lindgren CM, Stefansson K, Dermitzakis ET, Deloukas P, Spector TD, McCarthy MI. (2011). Identification of an imprinted master trans-regulator at the KLF14 locus related to multiple metabolic phenotypes. Nature Genetic. 43 (6): 561–564. |
[10] | Danquah I, Bedu-Addo G, and Mockenhaupt FP. (2010). Type 2 diabetes mellitus and increased risk for malaria infection. Emerging Infectious Diseases. 6 (10): 1601–1604. |
[11] | World Health Organization, “Trends in infection prevalence, case incidence and mortality rates” 2020. |
[12] | Steketee RW and Campbell CC. (2010). Impact of national malaria control scale-up programmes in Africa: Magnitude and attribution of effects. Malaria journal. 9 (1): 299. |
[13] | Crinnion WJ. (2011). Sauna as a valuable clinical tool for cardiovascular, autoimmune, toxicant-induced and other chronic health problems. Altern Med Rev. 16: 215–225. |
[14] | Hooper PL. (1999). Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med. 341: 924–925. |
[15] | Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, Koranyi L. (2002). Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes. 51: 1102–1109 |
[16] | Benjamin IJ, McMillan DR. (1998). Stress (heat shock) proteins: Molecular chaperones in cardiovascular biology and disease. Circ Res. 83: 117–132 |
[17] | Van Buskirk AM, De Nagel DC, Gualiardi LE. (1991). Cellular and subcellular distribution of PBP 72/74, a peptide-binding protein that plays a role in antigen processing. J Immunol. 146: 500–506. |
[18] | Van Molle W1, Wielockx B, Mahieu T, Takada M, Taniguchi T, Sekikawa K, Libert C. (2002). HSP70 protects against TNF-Induced inflammatory shock. Immunity. 16: 685–695 |
[19] | Zouari Bouassida K, Chouchane L, Jellouli K, Chérif S, Haddad S, Gabbouj S, Danguir J. (2004). Polymorphism of stress protein HSP70-2 gene in Tunisians: Susceptibility implications in type 2 diabetes and obesity. Diabetes Metab. 30 (2): 175–180 |
[20] | Paine SK, Basu A, Mondal LK, Sen A, Choudhuri S, Chowdhury IH, Saha A, Bhadhuri G, Mukherjee A, Bhattacharya B. (2012). Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes. Mol Vis. 18: 2749–2757. |
[21] | Cox AJ, Lambird JE, An SS, Register TC, Langefeld CD, Carr JJ, Freedman BI, Bowden DW. (2013). Variants in adiponectin signaling pathway genes show little association with subclinical CVD in the diabetes heart study. Obesity. 21: E456–E462. |
[22] | Sears IB, MacGinnitie MA, Kovacs LG, Graves RA. (1996). Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: Regulation by peroxisome proliferator-activated receptor gamma. Mol Cell Biol. 16: 3410–3419. |
[23] | Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Babu HNS, Rao MR, Mohan V. (2005). Peroxisome proliferator activated receptor gamma C coactivator–1 (PGC-1) gene polymorphisms and their relationship to type 2 diabetes in Asian Indians. Diabet Med. 22: 1516–1521. |
[24] | Cheema AK, Li T, Liuzzi JP, Zarini GG, Dorak MT, and Huffman FG. (2015). Genetic Associations of PPARGC1A with Type 2 Diabetes: Differences among populations with African Origins. Diabet Res. ID 921274, 10 pages |
[25] | Guewo-Fokeng M, Atogho-Tiedeu B, Sobngwi E, Mbanya JC, Mbacham W. (2016). The Krüppel-Like Factor 14 (KLF14) master gene of multiple metabolic phenotypes: Putative Trans-Regulator Network. J Transl Biomed. 7 (2):67. |
[26] | Clague MJ, and Urbé S. (2010). Ubiquitin: Same molecule, different degradation pathways. Cell. 143: 682-685. |
[27] | Kokura S, Adachi S, Manabe E, Mizushima K, Hattori T, Okuda T, Nakabe N, Handa O, Takagi T, Naito Y, Yosida N, Yoshikawa T. (2007). Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice. Int J Hypertherm. 23 (3): 259–265. |
APA Style
Magellan Guewo-Fokeng, Eugene Sobngwi, Barbara Atogho-Tiedeu, Jean-Claude Mbanya, Wilfred Mbacham. (2021). Heat Shock Protein 70 (HSP70) Protein-Protein Interactions and a Putative Mechanism for the Potential Benefits of Heat Therapy for Type 2 Diabetes Mellitus. Biochemistry and Molecular Biology, 6(2), 19-24. https://doi.org/10.11648/j.bmb.20210602.11
ACS Style
Magellan Guewo-Fokeng; Eugene Sobngwi; Barbara Atogho-Tiedeu; Jean-Claude Mbanya; Wilfred Mbacham. Heat Shock Protein 70 (HSP70) Protein-Protein Interactions and a Putative Mechanism for the Potential Benefits of Heat Therapy for Type 2 Diabetes Mellitus. Biochem. Mol. Biol. 2021, 6(2), 19-24. doi: 10.11648/j.bmb.20210602.11
AMA Style
Magellan Guewo-Fokeng, Eugene Sobngwi, Barbara Atogho-Tiedeu, Jean-Claude Mbanya, Wilfred Mbacham. Heat Shock Protein 70 (HSP70) Protein-Protein Interactions and a Putative Mechanism for the Potential Benefits of Heat Therapy for Type 2 Diabetes Mellitus. Biochem Mol Biol. 2021;6(2):19-24. doi: 10.11648/j.bmb.20210602.11
@article{10.11648/j.bmb.20210602.11, author = {Magellan Guewo-Fokeng and Eugene Sobngwi and Barbara Atogho-Tiedeu and Jean-Claude Mbanya and Wilfred Mbacham}, title = {Heat Shock Protein 70 (HSP70) Protein-Protein Interactions and a Putative Mechanism for the Potential Benefits of Heat Therapy for Type 2 Diabetes Mellitus}, journal = {Biochemistry and Molecular Biology}, volume = {6}, number = {2}, pages = {19-24}, doi = {10.11648/j.bmb.20210602.11}, url = {https://doi.org/10.11648/j.bmb.20210602.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bmb.20210602.11}, abstract = {The use of heat therapy to treat diseases was very common in Africa. To date, the number of people using this form of therapy is very much on the decrease. Data on the molecular action mechanisms of how it might induce beneficial effects remain unknown. The aim of the present study was to make a contribution towards understanding the putative implication of Heat Shock Protein 70 (HSP70) in the pathophysiology of Type 2 Diabetes Mellitus (T2DM) and the hypothetical benefits of heat therapy through the establishment of a network of protein-protein interactions between Krüppel Like Factor 14 (KLF14), Transcription Factor 7 Like 2 (TCF7L2), Peroxisome Proliferator-Activated Receptor Gamma (PPARG) and HSP70 (HSPA4). Data were generated by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) software version 10.0. This was used to identify the known and predicted protein-protein interactions (including direct or physical and indirect or functional associations) in the KLF14, TCF7L2, PPARG and HSP70 protein networks. With the active prediction methods (Gene Fusion, Neighborhood, Co-occurrence, Co-expression, Experiments, Databases and Text Mining) as interaction sources, Medium Confidence (0.400) and maximum number of interactions were used to show no more than 50 at the first shell and none at the second shell parameters. Fifty (50) proteins were identified to interact with these four proteins, namely KLF14, TCF7L2, PPARG and HSP70, resulting in a network diagram with 54 nodes (gene/proteins) and 485 edges, representing protein-protein associations. The network showed that HSP70 strongly interacts with other heat shock proteins like HSP90. The HSPBP, a cytoplasmic co-chaperone 1, inhibits HSPA1A chaperone activity by changing the conformation of its ATP-binding domain, thus interfering with this function. Based on the data generated by this in silico study, the potential beneficial effects of heat therapy on T2DM could probably be coordinated by the HSP70 protein-protein interactions involved in cell life and in the susceptibility to T2DM.}, year = {2021} }
TY - JOUR T1 - Heat Shock Protein 70 (HSP70) Protein-Protein Interactions and a Putative Mechanism for the Potential Benefits of Heat Therapy for Type 2 Diabetes Mellitus AU - Magellan Guewo-Fokeng AU - Eugene Sobngwi AU - Barbara Atogho-Tiedeu AU - Jean-Claude Mbanya AU - Wilfred Mbacham Y1 - 2021/05/08 PY - 2021 N1 - https://doi.org/10.11648/j.bmb.20210602.11 DO - 10.11648/j.bmb.20210602.11 T2 - Biochemistry and Molecular Biology JF - Biochemistry and Molecular Biology JO - Biochemistry and Molecular Biology SP - 19 EP - 24 PB - Science Publishing Group SN - 2575-5048 UR - https://doi.org/10.11648/j.bmb.20210602.11 AB - The use of heat therapy to treat diseases was very common in Africa. To date, the number of people using this form of therapy is very much on the decrease. Data on the molecular action mechanisms of how it might induce beneficial effects remain unknown. The aim of the present study was to make a contribution towards understanding the putative implication of Heat Shock Protein 70 (HSP70) in the pathophysiology of Type 2 Diabetes Mellitus (T2DM) and the hypothetical benefits of heat therapy through the establishment of a network of protein-protein interactions between Krüppel Like Factor 14 (KLF14), Transcription Factor 7 Like 2 (TCF7L2), Peroxisome Proliferator-Activated Receptor Gamma (PPARG) and HSP70 (HSPA4). Data were generated by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) software version 10.0. This was used to identify the known and predicted protein-protein interactions (including direct or physical and indirect or functional associations) in the KLF14, TCF7L2, PPARG and HSP70 protein networks. With the active prediction methods (Gene Fusion, Neighborhood, Co-occurrence, Co-expression, Experiments, Databases and Text Mining) as interaction sources, Medium Confidence (0.400) and maximum number of interactions were used to show no more than 50 at the first shell and none at the second shell parameters. Fifty (50) proteins were identified to interact with these four proteins, namely KLF14, TCF7L2, PPARG and HSP70, resulting in a network diagram with 54 nodes (gene/proteins) and 485 edges, representing protein-protein associations. The network showed that HSP70 strongly interacts with other heat shock proteins like HSP90. The HSPBP, a cytoplasmic co-chaperone 1, inhibits HSPA1A chaperone activity by changing the conformation of its ATP-binding domain, thus interfering with this function. Based on the data generated by this in silico study, the potential beneficial effects of heat therapy on T2DM could probably be coordinated by the HSP70 protein-protein interactions involved in cell life and in the susceptibility to T2DM. VL - 6 IS - 2 ER -